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Lectins and  other polyclonal lymphocyte stimulants  have  been used  extensively 
both to analyze early events in cellular activation and clinically as aids to the assess- 
ment of immunocompetence (1-5).  Earlier  studies  of the response of human blood 
lymphocytes to lectins provided suggestive evidence for heterogeneity of responding 
lymphocyte populations (6, 7). Chessin et al.  (6) showed that the lymphoblast popula- 
tion evident in pokeweed mitogen (PWM) 1 (Phytolacca americana) were separable into 
two  broad  catagories;  type  I  cells  which  were  indistinguishable  from  virtually  all 
lymphoblasts activated by phytohemagglutinin (PHA)  (Phaseolus vulgaris), and type 
II cells  which could not be found in PHA cultures and were distinguished by their 
higher cytoplasm to nucleus ratio, and lack of periodic  acid-Schiff-positive  (presum- 
ably glycogen) granules. 
These observations were made at a time when the dichotomy of lymphocytes into T 
and "bursal"-equivalent-derived (B) axis differentiation pathways (8) was not fully ap- 
preciated. Nevertheless, subsequent studies strongly supported the interpretation that 
T  cells responded to PHA whereas both T  and B responded to PWM. In particular, 
analyses  of  the  proliferative  and  biosynthetic  responses  to  PHA  and  PWM  with 
lymphocytes from both normal donors  (9)  and patients  with  selective  immunodefi- 
ciencies  (10-12) provided compelling support for the view that lectins could selectively 
trigger T  and/or B lymphocytes. This concept has been established  beyond question 
in animal model systems, particularly for the chicken (13-15) and mice (3, 4, 16) where 
appropriate manipulations are feasible and definitive cell markers and cell separation 
techniques are available.  In mice for example,  soluble PHA stimulates T  cells,  lipo- 
polysaccharide (LPS)  B cells, and PWM T plus B cells.  This selectivity may require 
some qualification, however, in terms of the culture conditions used and timing of the 
experiment and more especially of cellular interactions when T and B cells (plus macro- 
phages) are mixed together. Recently, marker systems and separation methods have 
become available which permit  the identification  and purification of human T- and 
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B-lymphocyte populations  (17,  19).  This new technology provides a  logical direct ap- 
proach  to establish  the precise selectivity of polyclonal stimulants for different popu- 
lations of human lymphocytes. 
We have studied  the response  capacity of T  and B  lymphocytes to a  variety 
of lectins and  other polyclonal stimulants  when cultured  as purified  cell popu- 
lations  or alternatively when  cultured  as mixed T-B  lymphocyte populations. 
The  identity  of  the  "starting"  cell  populations  and  the  activated  lympho- 
blasts  has  been  carefully established  using a  panel  of seven discriminating cell 
surface  markers.  Our  results  confirm  the  earlier  studies  of  Chessin  et  al.  (6) 
and  Douglas  et  al.  (10),  and  although  some interesting  species  differences  are 
evident  the  selectivity of polyclonal  stimulants  for  human  T  and  B  lympho- 
cytes is very similar to  that  observed earlier in rodents. 
Materials and Methods 
Cell  Sources.--Cell  separations  were performed on human  tonsil and  spleen cell suspen- 
sions.  Tonsils were available daily from the University College Hospital ENT Theatre and 
provided a  convenient source of over 2  M  l0  s viable lymphocytes/tonsil.  Spleens  were ob- 
tained from accident cases in the London area and in two instances from Hodgkins patients 
(shown subsequently to have no splenic involvement). Lymphocyte suspensions  were prepared 
as previously described  (20) using an Ultra-Turrax homogenizer and  filtration through glass 
wool. The working tonsil cell suspensions  in Earle's saline (ES) consisted of over 90% viable 
cells of which more than 95% were lymphocytes, less than 3% phagocytosed polystyrene par- 
tides  in  the  presence  of  50%  fetal  calf  serum  (FCS),  and  only  1-2%  had  monocyte/ 
macrophage morphology. The proportions of phagocytic cells in spleen suspensions were not 
routinely determined. 
Reagents for Selective Identification of Human T  and B  Cells.--Anti-T-cell serum (20) was a 
rabbit antihuman brain (cerebrum) serum absorbed with erythrocytes, liver, chronic lympho- 
cytic leukemic  (CLL)  ceils  (5;<),  and  acute myeloid leukemic cells  (2x).  Anti-B-cell serum 
(21) was a  rabbit  anti-CLL serum absorbed with erythrocytes, liver, and thymus cells (5x). 
Anti-T-lymphoblast serum was a pig antifetal thymus serum absorbed extensively with tonsil 
cells.  This serum reacts effectively with every thymocyte, and  stains no small T  or B  cells. 
It also fails to react with lymphoid cell lines and leukemic (lymphoid and myeloid) blast cells.  2 
Evidence for the selectivity of these  antisera  was  derived from  double-staining and  mixed 
fuorescence-rosette tests using antiimmunoglobulin  (Ig) as a  base-line marker for human  B 
lymphocytes and is published in detail elsewhere (20, 21). The anti-Ig used was a rabbit serum 
raised  against  human  IgG  myeloma  protein  and  was  absorbed  with  human  erythrocytes. 
Heat-aggregated human  IgG was prepared  by heating fluorescein-labeled serum IgG for 20 
rain  at  60°C  as described by Dickler and  Kunkel  (22).  Aggregates were ultrasonicated  im- 
mediately before use as indicators of Fc3, receptors on B cells. 
Enumeration of Human  T  and B Cells.--Enumeration of lymphocytes binding anti-T and 
B antibodies and anti-Ig was carried out using an indirect test with fluoresceinated goat anti- 
rabbit Ig or goat antipig Ig. Observations were made using a Vickers M41 Photoplan fluores- 
cence microscope (Vickers Instruments, Inc., Maiden, Mass.) equipped with an HBO-mercury 
lamp, incident illumination, and dichroic mirrors. The EAC test for C3 receptors present on a 
subset of B lymphocytes (23, 24) was carried out by sensitizing sheep erythrocytes  (SRBC) 
2 Greaves, M. F., G. Brown, and S. Lister.  1974. The expression of T  and  B-lymphocyte 
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with 1:64 rat 19S anti-SRBC serum at 4°C  for 60 min and subsequently coating with fresh 
mouse serum  (absorbed with SRBC)  at a  1:5 dilution for 30 min at 37°C.  Controls consisted 
of uncoated SRBC and SRBC coated with antibody only. The EAC test was performed  on a 
rotatory shaker at 37°C as described by Ross et al. (23). The E-rosette test for SRBC  binding 
by T  lymphocytes (25-27) was carried out by mixing 50X lymphocytes (107/ml) plus 50X heat- 
inactivated FCS (absorbed with SRBC) plus  100)t 2070 SRBC (less than 2-wk old). This mix- 
ture was centrifuged at 175 g at 20°C  and the rosetted pellet left at room temperature for 60 
rain before careful resuspension by tapping. E and EAC rosettes were enumerated by observa- 
tions either on unstained wet preparations in a hemocytometer, or as in the case of activated 
lymphoblast  suspensions  by  staining in  suspension  with  0.1%  toluidine  blue  (M.  Pepys, 
personal communication) add  mounting on a  slide. Cells  binding three or more SRBC were 
considered as rosette-forming cells.  In some experiments polystyrene particles were  added  to 
identify mononuclear phagocytes. 
Lymphoblasts from cultures were washed three times before assay with cell surface markers. 
Cell aggregates were broken up by vigorous pipetting in cold ES and in occasional experi- 
ments by using an Ultra-Turrax homogenizer. Lymphoblasts were classified as such in marker 
experiments by virtue of their large size (>2 times the control small lymphocyte diameter), 
by the lack of phagocytic capacity, and by their general optical properties. 
In all experiments the lymphoblasts reactive with given markers on day 3-4 of culture were 
calculated in absolute numbers. This type of analysis provides an approximate guide to  the 
responding cell pool. Accurate estimates are rendered more difficult by cell death and prolifera- 
tion during the culture period. 
Purification  of Human T and B Cells.--T lymphocytes were purified by a nylon wool column 
filtration method (28),  based on that described by Julius et al.  (29) for rodent cells.  Recently 
Eisen et al.  (30)  have reported the use of a similar method for purifying human T  cells  from 
blood. 
B  lymphocytes were purified by sedimentation of E  (i.e.,  T)  rosettes on Ficoll-isopaque 
(28,  31). Table I  summarizes the cell surface characteristics of  the cell populations used in 
this study. 
Culture  Media.--Two  different media  were  used.  Dulbecco's modified  minimal essential 
medium (D-MEM) was supplemented with 10% heat-inactivated human AB serum.  RPMI- 
1640  medium  (Flow Laboratories, Ltd,  Irvine, England) was supplemented with 10% fetal 
bovine serum  (batch no. 0186,  Biocult Laboratories, Ltd, Paisley, England) unless otherwise 
stated.  Both  media  were  further  supplemented with  glutamine  (300  mM)  and  antibiotics 
(penicillin, 200 U/ml; streptomycin,  100 #g/ml).  Under the culture conditions used the pH 
of the two media are slightly different (D-MEM, pH 7.0;  RPMI, pH 6.8). 
Culture  Conditions.--Culture  vessels with flat  bottoms were  used.  For studies in which 
responses were evaluated by isotope uptake a microplate method was applied (32). The plates 
(Microtest II, catalogue no. M-29-ART Flow Laboratories, Ltd) contained 96 wells, each with 
28 mm  2 surface area (of bottom). The culture volume was 0.25 ml and the initial cell number 
was 3  X  105 lymphocytes/0.25 ml (1.2  ~<  106/ml), unless otherwise stated. The cell suspen- 
sions were distributed by a Repette syringe (Jencons, Hemel Hempstead, England) and stimu- 
lants were added by a Hamilton microsyringe (100 #1) adjusted into a modified repeating dis- 
penser (Hamilton; Howe  & Co.  Ltd, London, England). For cytological analysis 2.4  X  l0  G 
lymphocytes/2-ml medium were cultured in plastic vials (bottom area 180 mm  2, catalogue no. 
118/S, Sterilin Ltd, Richmond, England). The plates, covered with lids, and vials were placed 
into a  dessiccator and gassed with 5% CO2 in air. The microcultures were usually set up in 
triplicate and the vials were set up in duplicate. 
Stimulants  Used.--PHA  (purified  PHA,  Burroughs  Wellcome  Labs  Ltd,  Beckenham, 
England)  and LPS from Salmonella  marcescens (purified by Westphal method catalogue no. 
3130-25-8 Difco Laboratories, East Molesey, England) were used in different doses and val- ACTIVATION  OF  HUMAN  LYMPHOCYTES 
TABLE I 
Ccll Surface Markers and Cell Populations Used 
%  Reactive cells 
Cells  T lymphocyte  markers  B lymphocyte  markers 
anti-B  sera 
Tonsil 
Unseparated 
T  cells:  single 
cycle* 
B  cells: single 
cycle~  [ 
double I 
cycle§ 
Spleen  I 
Unseparated  I 
B  cells: double 
cycle 
anti  T  scr_____A  1 
52.8  -4-  1.9 54.8 ~  1.6 
95  (4)  I  94  ~  0.8  (27) 
I 
/  1.3  (3)  I  1.9  q-  0.3  (6) 
--  <0.05  (s) 
--  34.6  (3) 
--  <0.0,5 
14.5  ±  2.3 
1.8  (4) 
97.1  (4) 
m 
anti-Ig  EAC(C3) 
43.2  :[:  1.8  34.0  :t:  2, 
2.1  -4- 0.3  (27:  0.2  (2) 
96.7  -4-  1.5  (6)  79.3  (3) 
97.6  (5) 
4L2  (2) 
Mononu- 
clear 
phago- 
Aggregated IgG  cytes[l 
43.1  d:  3.1  (7)  0.5-2  (5) 
1.8 (3)  <0.  I (5) 
86.4  (3)  3.1  (2) 
3.2  (2) 
S.0  (1) 
* Yield of T  cells, 49 q- 2.9. Mean values =t= standard error. 
$ Yield of B  cells, 84  q- 3.1. 
§ Yield of B  cells, 75.8 q- 8. 
IJ Phagoeyto6is of latex particles over  a 60-rain period in the  presence of 50%  FCS.  Cells examined in suspension  by 
phase contrast and as stained preparations after smearing (cytoceutrifuge). 
ues observed at  optimal doses  (1-2  ~g/ml  and 30-60  #g/ml, respectively)  are given. Con- 
canavalin A (Con A, Pharmacia Fine Chemicals, Ltd, London, England) was used in optimal 
stimulating  doses  (3  /~g/ml).  Pokeweed  mitogen  (PWM)  was  purified  from  plant  stems 
(Phytolacca americana) by the method of  B6rjeson et  ai. (6). The redissolved TCA-precipi- 
tared  material was used and applied in a  50/~g/ml dose,  unless otherwise stated) 
Measure of Isotope Incorporation.--After 48  h  of  cultivation  1  /~Ci [3H]thymidine  (50 
mCi/mmol spec act, prepared from TRA 120, The Radiochemical Centre, Amersham, England) 
was added to the microcultures. In one experiment 0.1/~Ci [ZH]thymidine  of high spec act (20 
Ci/mmol, TRK 120, Rad iochemical Centre) was added  to some cultures.  16 h  later the sus- 
pension from each well was  assayed for thymidine uptake as previously described (32, 34). 
Autoradiography.--Affer 60 h  of  incubation  [3H]thymidine  (100 mCi/mmol, 8  /~Ci/ml) 
was added to the cultures. After an additional 16-h incubation the number of surviving small 
and  large  cells  (lymphoblasts)  were  determined.  To  analyze  the  proportion  and  struc- 
ture  of labeled cells within the blastoid cell population, smears were prepared  with a cyto- 
centrifuge  (Shandon  Scientific Co., Camberley, England)  Filter papers  were wetted  before 
adding the cell suspensions.  Two autoradiographs/culture were prepared by the stripping film 
technique  (Kodak AR.10 film, 5  days of exposure). Smears were finally stained with hema- 
toxylin and eosin. 
RESULTS 
Analysis  of  Purified  Tonsil  T  and  B  Cells  Activated  by Mitogens.--Fig.  1 
illustrates  the  results  of analysis  of purified  tonsil  T  and  B  cells activated  by 
various mitogens for 3  days in D-MEM/human  serum (HS) medium. As shown 
8 Staphylococcal enterotoxin "B" (SEB) was a gift from Dr. W. Adler and was a purified 
protein preparation  (33). lO0 
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FIG. 1.  Response of tonsil T and B lymphocytes to polyclonal mitogens. [], lymphoblasts 
verified as T  type by surface marker  analysis. ,, lymphoblasts verified as B type by surface 
marker  analysis. Absolute numbers of lymphoblasts were counted and  the level of response 
expressed in relation  to the initial number of cells in the culture. C, control; T  -t- B, unsep- 
arated tonsil cells; T, purified T cells (see Table I) ; B, purified B cells (double cycle) (see Table 
I); and B(-{-T), purified B cell (single cycle) (see Table I). 
in  Fig.  1,  T  cells are  the predominating  responsive  cells in T-B  mixtures.  In 
PHA-  and  SEB-stimulated  cultures  92-96  and  85-93%,  respectively,  of 
blastoid  cells  were  of T-cell origin.  The  PWM  response  was slightly variable 
and  T  blasts  contributed  70-83 %;  while  the majority of the  remaining  large 
blastoid population  (17-30%)  was carrying surface Ig (B  blasts).  No LPS re- 
sponse  was evident  in any experiments  with  tonsil  cells.  Similar  results  were 
obtained  in  five further experiments. 4 Purified T  lymphocytes responded  well 
to PHA, PWM, and  SEB. More than 99 %  of lymphoblasts in  these  cultures 
were verified as T  lymphoblasts by surface marker analysis. 
The purified B-cell population response depended to a considerable extent on 
the degree of T  cell  "contamination."  In cultures with  single cycle-purified B 
cells  which  contained  1-3 %  T  cells  a  considerable  response  was  evoked  by 
PHA,  SEB,  and  PWM.  Analysis of cell  surface  phenotype  of these  lympho- 
blasts revealed, however, that a significant proportion were T  cells, presumably 
4 Virtually identical results were obtained in three experiments with ficoll-isopaque-purified 
blood lymphocytes.  Greaves and Janossy,  unpublished  observations. ACTIVATION  OF HUMAN  LYMPHOCYTES 
derived from the residual small number of contaminating T  lymphocytes. This 
was particularly so in PHA cultures where approximately 90 % of lymphoblasts 
were in fact T  cells.  When  B  cells  were more extensively purified by double 
cycling  (see  Materials  and  Methods)  a  different  result  was  obtained.  The 
PHA response was completely absent and the PWM  and SEB were consider- 
ably reduced. Responses to the latter two mitogens were, however, significant 
and more than 95 % responding lymphoblasts had the B-cell surface phenotype 
in three such experiments. 
In  further experiments we  have performed cell  surface marker analysis  of 
lymphoblasts  in  mixed  T-B  lymphocyte cultures  stimulated  by  low,  inter- 
mediate,  and  high  (with  respect  to  [~H]thymidine uptake)  doses  of  PWM, 
PHA, and SEB. The B-cell contribution to these responses was slightly greater 
at  lower  doses,  however,  it  only ever accounted for more  than  20%  of  the 
responding cell pool when PWM was the mitogen used. 
The  T-Cell  Dependency of  Thymidine  Uptake in  Short-Term  Cultures of 
Tonsil Lymphocytes with PHA.--The results of cell surface marker analysis of 
activated lymphoblasts in tonsil cultures indicated that the response of T  plus 
B  lymphocytes was predominantly expressed by the former cell  type and re- 
sponses observed in "purified" B-cell populations attributable at least in part 
to  contaminating  T  cells.  The T-cell  dependence  of  the  PHA  response was 
further established by a  study of the uptake of thymidine by activated cells. 
When purified T  and B lymphocytes were remixed together at varying propor- 
tions and stimulated by PHA it is clear that the response observed is propor- 
tional to the T-cell numbers (Fig. 2). The exact relationship between counts of 
radioactivity and numbers of responding T  cells is however not precisely linear. 
Elaboration  of  Culture Conditions for  B-Lymphocyte  A ctivation.--In  the 
second part of this study we employed conditions which we had reason to be- 
lieve would be more likely to permit  good  B-lymphocyte responses. Namely 
the use of RPMI  FCS medium and spleen cells.  The proportion of B  cells  in 
tonsil T- plus B-cell cultures responding to PHA and SEB is slightly elevated in 
our hands  (up to 20 %) by the use of the above medium. Experiments in mice 
have indicated that spleen B lymphocytes respond better to mitogenic stimuli 
(PWM,  LPS)  than  B  cells in  lymph nodes,  Peyer's patches,  and  blood  (M. 
Doenhoff, unpublished observations). 
Thomas and Phillips  (personal communication) have made similar observa- 
tions although  their B-cell response to  PHA  (35,  36)  is  considerably greater 
than what we observe under any conditions (see Discussion). 
Surface  Marker  Analysis  of A ctivated Splenic  Lymphocytes.--The  results of 
an analysis of activated splenic lymphocytes RPMI/FCS  are given in Fig. 3. 
An excellent PHA response was observed in T- plus B-cell cultures; B lympho- 
cytes contributed only 14% of the responding cells.  The results with SEB as 
mitogen were virtually the same  as with  PHA. The  PWM  response differed 
significantly from the tonsil response, in involving a much higher proportion of 
B cells (85 % of the lymphoblasts were B cells). MELVYN  GREAVES~  GEORGE  JANOSSY,  AND  MICHAEL  DOENttOFF  7 
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FIG.  2. Thymidine  uptake  in  PHA-stimulated  tonsil lymphocyte  cultures  containing 
variable propertions of T and B cells. Double cycle-purified B cells and single cycle-purified  T 
cells mixed at variable proportions before culture. Total lymphocyte numbers the same in all 
cases. 
Double cycle-purified B cells responded well to PWM, and activated lympho- 
blasts were virtually all verifiable B  cells by surface marker analysis (see also 
below). Small B-cell responses to LPS and SEB  were detected but  no B  cells 
responded to PHA under these conditions. 
The  Proliferative Responses in Spleen  Cullures.--Two  different  approaches 
were used.  First,  the uptake of [aH]thymidine was determined during 48-64 h 
of  culturing.  Second,  cells  were  labeled  with  [aH]thymidine  during  60-76  h 
and then autoradiographic analysis was carried out. 
As can be seen in Fig. 4 the thymidine uptake in the early cultures (48-64 h) 
of mixtures of T-B cells was highest in cultures with activated T  lymphocytes 
(in PHA- and SEB-stimulated cultures, particularly in D-MEM/HS medium). 
There was excellent thymidine uptake in PWM-stimulated cultures, and on the 
basis of the high number of B lymphoblasts in these cultures (cf. Fig. 3), it can 8  ACTIVATION  OF  HUMAN  LYMPHOCYTES 
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FI6. 3.  Response oI splenic T and B ]ymphocytes to polyclonal mitogens in RPMI  1640 
mediufia. Legend as in Fig. 2. Double cycle-purified B cells (see Table I). 
be assumed that activated B  cells have in fact contributed considerably to the 
observed uptake of thymidine. LPS was a  relatively poor stimulant of human 
spleen lymphocytes. 
It is interesting,  however, that there was a  relatively low thymidine uptake 
in the pure B-lymphocyte cultures stimulated by all mitogens in such an early 
phase of the  response, in  spite of the  remarkable blast  transformation in  the 
PWM-stimulated  B-cell  cultures.  One  possible  interpretation  of  this  data  is 
that in  the absence of T  cells the onset of proliferative response of B  cells to 
PWM is delayed for a  few hours as compared to PWM-stimulated cultures of 
T  and B  cells.  This was suggested by the autoradiographic analysis when cul- 
tures were labeled with [~H]thymidine during a slightly later period (60-76 h). 
If cultures of double cycle-purified B cells were incubated  with  PWM,  a  high 
proportion, but not all, of the activated large lymphoblasts were labeled (Fig. 
5 c). This picture was altogether very different from that of PHA-incubated pure 
B-cell cultures, where only very few lymphoblasts could be seen and even fewer 
of them were labeled  (Fig.  5  b). Occasionally, labeled blasts could be seen in 
unstimulated control cultures, too (Fig. 5 a). 
Persistence of SurfaceMarkers on Activated T and B  Lymphoblasts In  Vitro.- 
Since  the panel  of cell  surface markers we, and  others,  have used have been MELVYN GREAVES, GEORGE JANOSSY, AND MICHAEL DOENHOFF  9 
FIG. 4.  Proliferation response of splenic lymphocytes to polyclonal mitogens. Legend as in 
Fig. 1. m, Dulbecco's MEM/HS; and D, RPMI 1640/FCS. B, double cycle purified (Table I). 
developed and assessed for specificity primarily on the basis of their reactivity 
with  small  lymphocytes  the  approach  used  in  this  study  provides  a  useful 
means to establish the persistent expression of the various markers when cells 
are cultured  and pass through mitotic cycles (37).  Our  standard  experiments 
have  employed  anti-T-cell  serum  and  E  rosettes  as  routine  T-cell  markers, 
and  anti-Ig  and  anti-B-cell  serum  as  B-lymphocyte markers.  In  additional 
experiments, however, we have added the three additional markers mentioned 
in  the Materials and Methods  section,  namely antithymocyte and T-lympho- 
blast serum, EAC rosettes (for B-cell subset), and aggregated IgG for B  cells. 
The pooled results from a series of experiments are given in Fig. 6. It should be 
noted that the slight expression of T-cell markers in B-cell responses is due to 
the presence of a  small proportion  of T  lymphoblasts in LPS-stimulated un- 
separated  (T  and  B)  spleen  cells.  Less  than  1%  of  PWM-activated  B  cells 
have any of the three T-cell markers. These results confirm the selectivity of 
the markers established on noncultured small lymphocytes and moreover indi- 
cate that all markers are stable,  continuously synthesized, and not lost when 
cells become activated and enter the cell cycle. However, since only a subset of 
B lymphocytes express the C3 receptor before activation (Table I), we cannot 
rule out the possibility that some B cells gain or lose this receptor during activa- 
tion. All seven markers have given similar results when applied to continuous 
lymphoblast  cell  lines. 5 One  slight,  but  very  interesting,  discrepancy  does 
emerge from this study however, which is the apparent expression on a  small 
minority of activated T  cells of binding sites for aggregated immunoglobulin. 
5 Greaves, M. F., G. Brown, and M. Epstein, manuscript submitted for publication. FIG. 5.  Autoradiographic analysis of mitogen-acfivated splenic lymphocytes (a)  Control 
(unstimulated cultures).  (b)  PHA-stimulated  culture.  (c)  PWM-stimulated  culture.  (see 
Materials and Methods for conditions of experiment). X  860. 
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We  have previously observed a  similar  result  with  T  lymphoblasts  present 
in the tonsil suspensions immediately after initial preparation (20). 
DISCUSSION 
The purpose of this study was to map the previously described heterogeneity 
of PHA and PWM responses of human lymphocytes onto the well established 
dichotomy of lymphocytes into T- and B-cell categories. Our precedent was the 
already established selective response of these two major lymphocyte popula- 
tions, in mice, to various polyclonal stimulants  (3, 4,  16, 38). The application 
of a panel of seven discriminating markers for cell surface molecules on T and B 
lymphocytes combined with cell purification methods have provided a reliable 
basis  for the  identification of T-  and  B-axis  cells  responding  to  lectins and 
bacteria-derived mitogens. Activation of purified T  and B  cells over a  4-day 
period in vitro revealed that  the cell  surface markers  used were consistently 
expressed in a selective manner and stable during the cell cycle. 
We have restricted our attention to the relatively early culture period of the 
first 4 days, because this is when we consider it easier to establish quantitative 
relationships. It is readily apparent that the T- and B-lymphocyte response to 
polyclonal mitogens  in  man is  influenced by the  source of lymphocytes, the 
cellular composition of the culture (i.e. proportions of T  cells,  B cells and pos- 12  ACTIVATION  OF  HUMAN  LYMPIIOCYTES 
sibly other cells including macrophages), the culture media, and the particular 
mitogen used. The experimental  model is,  in other words, complex and subject 
to a variety of qualifications. In Table II we have attempted to summarize the 
relative response capacity of T  and B cells to various polyclonal mitogens under 
our culture conditions. 
When T  and  B  lymphocytes from blood,  tonsil,  or spleen  are  cultured  to- 
gether  the  contribution  of T  and  B  cells  to the  PHA and  PWM  responses  is 
rather what would be suspected from earlier,  less direct,  studies in man  (6, 9) 
FIG. 6.  Expression of T- and  B-lymphocyte  cell surface  markers  on activated  lympho- 
blasts,  m, T  lymphocytes from tonsil activated  by PHA, Con A, PWM, and  SEB  (pooled 
data).  [], Spleen cells activated by LPS and purified spleen B lymphocytes activated by PWM. 
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and parallel studies in mice (3, 16, 38, 39). The PHA response is dominated by 
the T-lymphocyte component, whereas the PWM response is more of a mixture. 
The relative contribution of B cells to the PWM response depends on cell source 
and culture medium used, and was most pronounced when spleen cells were cul- 
tured in RPMI plus FCS medium. Although the B-cell contribution was con- 
sistently low in PHA cultures; we do not exclude the possibility suggested by 
other experiments in man (35) and mice (40, 41) that different culture conditions 
or time of assay (i.e., late) might provide a different picture in which activated 
B cells are more prominent. What is important to consider however is whether 
conditions for exclusive T-cell activation are available and the extent to which 
any observed B-cell responses are T-cell dependent. We consider that the first 
point is in part fulfilled by the results we described, namely that when T  and 
B cells are grown in D-MEM/HS medium for 3 days over 95 % of the activated 
lymphoblasts are T  cells.  Combined marker analysis plus autoradiography will 
be required to establish whether the very small B-cell component of response 
actually contributes anything at all to the response as measured by thymidine 
incorporation. 
T  cells purified from tonsil responded  well  to PHA, PWM, and  SEB. We 
conclude that  this response is independent of macrophages although a  facili- 
tating role of the 5 %  non-T and non-B  cells in these cultures has not been 
excluded. The exact proportion of human T cells responding to these polyclonal 
stimulations has not been assessed; however our results and previous studies in 
rodents (32) suggest that greater than 50% probably do respond. This value 
could however vary with the source of T  cells and differential T-subset distri- 
bution (2). It is interesting to note that T cells that have responded previously 
to major histocompatibility antigens may be unreactive to polyclonal mitogens 
(42).  B  lymphocytes purified from spleen and  tonsil  responded to PWM  al- 
though only the former source provided a highly responsive population. 
The splenic B-cell proliferative response to PWM is delayed with respect to 
that of T  cells,  which differs from our previous observations in mice where B 
cells,  if anything,  respond rather  sooner than T  cells as judged  by chromo- 
some marker analysis (43). Other studies of PWM responsiveness in man also 
suggest that the optimal B-cell response may be delayed relative to the T-cell 
responses (10, 44). 
Under  conditions where  B  cells are  responding well  to  PWM  in  terms of 
lymphoblast formation and thymidine incorporation (Fig. 6),  there are weak 
responses to LPS and SEB ; this is in contrast to studies in mice where LPS is a 
more potent B-cell mitogen (3-5). Spleen and tonsil B cells do not respond at all 
under our culture conditions to PHA, although a small response was evident 
(Fig. 1) in cultures with 1-3 % residual T  cells.  In this situation, however, the 
majority of the activated lymphoblasts are in fact T  cells. This result suggests 
that marginal B-cell responses to PHA as seen in cultures of T  and B cells are 
probably T-cell dependent. This interpretation is supported by the demonstra- 14  ACTIVATION OF HUMAN LYMPHOCYTES 
tion (Fig. 3) that the PHA response in artificial graded T- and B-mixed cultures 
is proportional to the T-cell proportion. 
These are perhaps the results one might have anticipated from parallel experiments 
in rodent and chicken systems and from studies of selective immunodeficiency diseases 
in man. However, our inability to stimulate B  cells with PHA, in the absence of T 
cells, contrasts with the recent results of Phillips and colleagues (35,  36), who have 
reported that human tonsil B cells absorbed into Sephadex anti~Ig columns and eluted 
by digestion of the absorbent support by dextranase, do in fact respond by lympho- 
blast activation and DNA synthesis. These authors also report  a considerably more sub- 
stantial contribution of B cells to the PHA response in T-B cell mixtures. The finding 
that a  large proportion of PHA-activated blood-derived lymphoblasts have readily 
demonstrable Ig light chain determinants (45, 46) may also be taken to reflect a con- 
siderable contribution of B  cells to PHA-induced responses of mixed T- and B-cell 
cultures. The reason for these discrepancies is unclear. We think it unlikely that our 
culture conditions are inimical to B-cell responses since we have the positive control 
of the PWM response, at least with spleen B cells. In addition our media and general 
conditions are in fact the same as those used by Phillips and colleagues. While we are 
reluctant to rule out that minor variations in culture conditions can radically effect 
B-cell responsiveness, we consider that several other interpretations of the reported 
PHA response of purified B  cells (35, 36) are possible: (a) That some B cells respond 
to PHA in the presence or T  cells. Our results with T-B mixtures support the possi- 
bility, however, as shown above when B-cell cultures were "contaminated" with only 
2-3% T  cells the majority of the small pool of responding lymphoblasts were T  cells. 
Some evidence for activation of mouse B cells by soluble lectin (Con A) in the presence 
of supernates of activated T cells has been presented (4, 47), however, in our experience 
these synergistic effects are quite small in relation to a "direct" B-cell mitogen such as 
LPS or PWM (43). (b) That B cells will respond to PHA in the presence of adequate 
numbers of macrophages. Evidence for macrophage facilitation of PHA responses is 
available (48) and recent work suggests that human B-cell activation detectable after 
7 days in culture may be induced by PHA in the presence of macrophages (49).  This 
is also unlikely to be the explanation for the discrepancy in results under discussion, 
since both ourselves and Phillips and colleagues used similar cell preparations from 
tonsils. (c) We consider it necessary to exclude that B  cells purified by elution from 
insoluble anti-Ig absorbents are not in fact subliminally stimulated by anti-Ig anti- 
bodies. Clear precedents for such effects have been reported (50, 51). "Priming" of B 
cells by anti-Ig might well render them responsive to subsequent challenge with PHA. 
Clearly, B  cells have PHA binding sites (52)  and are not obligatory nonresponders as 
evidenced by experiments with insolubilized PHA (53). 
It is relevant to this discussion that  cytotoxic anti-human T-cell sera have 
been  found  to  completely abolish  the  PHA  response,  providing  further  evi- 
dence  that  under  most  conditions  the  PHA  response  is  certainly  thymus 
dependent  (references 54  and  55,  and  footnote  6).  Finally,  the  response  to 
PHA is effectively absent in cultures of lymphocytes from patients with thymic 
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aplasia (56,  57). Although the remarkably quick return of PHA responsiveness 
after thymus grafting (references 56 and 57,  and footnote 7)  poses intriguing 
problems regarding the origin and nature of responsive cells,  these observations 
are clearly indicative of the thymus dependency of PHA responses. 
We conclude that our results confirm the earlier suggestion (6,  9)  that PHA 
primarily stimulates T  lymphocytes and PWM,  T  and B  cells.  This pattern 
of selectivity parallels that found in the mouse (39,  40). 
The  PHA  response  can  therefore  be  used,  under  controlled  conditions  of 
cellular composition, culture media, and assay, as a  qualitative or semiquanti- 
tative measure of the capacity of blood-borne T  cells to become activated and 
to divide. At present there appears to be no polyclonal mitogen that will pro 
vide the same opportunity to study B lymphocytes in blood. 
SUMMARY 
Human  lymphocytes from  spleen  and  tonsils  have  been  cultured  with  a 
variety of  polyclonal  mitogens.  Cultures  consisted  of  either  unseparated  T 
and B  cells or alternatively purified T  or B  lymphocytes. The purity of the 
starting cell populations and the origin of activated lymphoblasts was analyzed 
with a panel of seven markers which discriminate between T  and B  cells.  The 
selectivity of the lymphocyte responses was influenced by cell populations in a 
given culture, the mitogen used, and to a limited extent on culture conditions. 
Purified T  lymphocytes from tonsil  and spleen responded to phytohemagglu- 
tinin  (PHA),  pokeweed mitogen  (PWM),  and  staphylococcal  enterotoxin  B 
(SEB).  Purified  B  cells from spleen responded well to PWM,  weakly to SEB 
and lipopolysaccharide, but not at all to PHA. Tonsil B cells responded weakly 
to PWM and SEB but not to PHA. Some B lymphocytes do respond to PHA in 
the presence of activated T  cells.  These results are discussed in relation to pre- 
viously  reported  selective  responses  of  human  cells  and  parallel  studies  in 
animal species. 
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